Review ArticleJournal of Young PharmacistsVol. 17 | Issue 4 | 2025 | pp. 770–776Open access
Artificial Intelligence in Hemovigilance: Advancing Blood Safety and Monitoring Systems
- 1*,
- 2,
- 2
- 1 Chettinad School of Pharmaceutical Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, INDIA.
- 2 Department of Pharmacy Practice, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, Ramachandra Medical College, Sri Ramachandra Nagar, Porur, Chennai, Tamil Nadu, INDIA.
Published in Journal of Young Pharmacists
Correspondence: Ragesh Gurumoorthy
Chettinad School of Pharmaceutical Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, INDIA.
Email: rageshgurumoorthy@care.edu.in
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Nov 8, 2025
- Received:
- Jun 9, 2025
- Accepted:
- Sep 22, 2025
- DOI:
- 10.5530/jyp.20251751
How to cite
Gurumoorthy, R., Thiyagarajan, K., & Ganesan, S. K. (2025). Artificial Intelligence in Hemovigilance: Advancing Blood Safety and Monitoring Systems. Journal of Young Pharmacists, 17(4), 770–776. https://doi.org/10.5530/jyp.20251751
Abstract
Blood transfusion is one of the key practices in making sure that the safety of the patients remains intact; however, traditional systems are being faced with a substantial number of challenges, such as underreporting utility of data integration issues and slow response time. Artificial Intelligence (AI) technology brings new light in dealing with these problems by means of the integration of advanced information systems that could differentiate, find out, and report the transfusion cases. This review discusses the potential of emerging AI in advancing hemovigilance by way of integrating natural language processing to support data integration, machine learning models for the detection of adverse events, and predictive analytics for personalised risk management. AI technologies are further implemented in the supply chain to improve the blood supply by the application of optimisation techniques of demand forecasting and waste reduction. It is important to note that even though hemovigilance systems' AI-based solutions ensure safe patient care and efficient operation, there are always some problems faced by AI-based technologies, for example, data privacy, algorithmic biases, and inadequate regulatory frameworks, which might cause unnecessary obstructions. In the future, effective privacy-enhancing methods will be developed, like federated learning, in addition to Explainable AI (XAI) for the human building of robust, transparent, and secure AI hemovigilance systems. This review stresses that AI will play a vital role in the future of transfusion by improving the safety and efficiency of medical services eventually.
Keywords
Subject
Article metadata
| Title | Artificial Intelligence in Hemovigilance: Advancing Blood Safety and Monitoring Systems |
|---|---|
| Authors | Ragesh Gurumoorthy; Karthik Thiyagarajan; Santhosh Kumar Ganesan |
| Affiliations | Chettinad School of Pharmaceutical Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, INDIA.; Department of Pharmacy Practice, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, Ramachandra Medical College, Sri Ramachandra Nagar, Porur, Chennai, Tamil Nadu, INDIA. |
| Corresponding author | rageshgurumoorthy@care.edu.in |
| Journal | Journal of Young Pharmacists |
| Volume / Issue | Vol. 17, Issue 4 (2025) |
Also in this issue
- Dual Nephroprotective Strategy of Dapagliflozin and Telmisartan in the Management of Diabetic Kidney Disease: A Comprehensive Reviewpp. 752–762
- Pharmacological Approaches in Alcohol Use Disorder-Exploring Off-Label an Emerging Treatments in Clinical and Preclinical Evidencepp. 763–769
- Advances in Green Analytical Techniques for Impurity Profiling in Pharmaceuticalspp. 777–783
- Pharma 4.0: Enhancing Process Robustness in Pharmaceutical Manufacturing through Industry 4.0 Integrationpp. 784–789
- Ferroptosis as a Therapeutic Target: Advances in Drug Development for Cancer and Neurodegenerative Diseasespp. 790–796
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026